Assembly Biosciences, Inc. Increase (Decrease) in Deferred Revenue
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Deferred Revenue of -$996.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2019-08-05
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2019-06-30 was -$137.00K.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2019-03-31 was -$859.00K.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-12-31 was -$1.26M.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$1.67M.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2018 was -$5.13M, a 111.19% decline from fiscal 2017.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2017 was $45.78M.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2016 was $0.00.
- Assembly Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2015 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$996.00K 10-Q · filed 2019-08-05 | -$2.26M derived: sum of 3 quarters · filed 2019-08-05 | -$3.93M derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2019-03-31 | -$859.00K 10-Q · filed 2019-05-09 | -$2.12M derived: sum of 2 quarters · filed 2019-05-09 | -$3.79M derived: sum of 3 quarters · filed 2019-05-09 | -$4.68M derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2018-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$2.93M derived: sum of 2 quarters · filed 2019-02-28 | -$3.82M derived: sum of 3 quarters · filed 2019-08-05 | -$5.13M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | -$1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$2.56M derived: sum of 2 quarters · filed 2019-08-05 | -$3.86M 10-Q · filed 2018-11-08 | -$4.89M derived: sum of 4 quarters · filed 2019-08-05 | |||
| 2018-06-30 | -$894.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$2.19M 10-Q · filed 2019-08-05 | -$2.19M 10-Q · filed 2018-08-08 | -$3.22M derived: sum of 3 quarters · filed 2019-08-05 | -$4.48M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | -$1.30M 10-Q · filed 2019-05-09 | -$1.30M 10-Q · filed 2018-05-07 | -$2.33M derived: sum of 2 quarters · filed 2019-05-09 | -$3.59M derived: sum of 3 quarters · filed 2019-05-09 | -$4.83M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$2.29M derived: sum of 2 quarters · filed 2019-02-28 | -$3.53M derived: sum of 3 quarters · filed 2019-02-28 | $45.78M 10-K · filed 2019-02-28 | $45.78M 10-K · filed 2018-03-08 | ||
| 2017-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$2.50M derived: sum of 2 quarters · filed 2018-11-08 | $46.81M 10-Q · filed 2018-11-08 | $46.81M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $48.07M 10-Q · filed 2018-08-08 | $48.07M derived: sum of 3 quarters · filed 2019-02-28 | $48.07M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $49.32M 10-Q · filed 2018-05-07 | $49.32M derived: sum of 2 quarters · filed 2019-02-28 | $49.32M derived: sum of 3 quarters · filed 2019-02-28 | $49.32M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | ||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | ||||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |